Yu et al., 1993, Biochem. Biophys. Res. Commun. 191:207-213. |
Pennington et al., 1994, Methods Molec. Biol. 35:1-16.* |
Neurath et al, Radioimmunoassay and Enzyme-Linked Immunoassay of Antibodies Directed Against Lymphadenopathy-Associated Virus (LAV) Proteins Larger than the Core Protein (P24), J Virol. Methods, 12:85-92 (1985). |
Wong-Staal, et al. “Genomic Diversity of Human T-Lymphotropic Virus Type III (HTLV-III),” Science 229:759-62 (1985). |
Barré-Sinoussi, et al. “Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS),” Science 220:868-871 (1983). |
Wain-Hobson et al., “Nucleotide Sequence of the AIDS Virus, LAV”, Cell, 40:9-17, (1985). |
Ratner et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III,” Nature, 313:277-284 (1985). |
Sanchez-Pescador et al., “Nucleotide Sequence and Expression of an AIDS-associated Retrovirus (ARV-2),” Science, 227:484-492 (1985). |
Muesing et al., “Nucleic Acid Structure and Expression of the Human AIDS/Lymphadenopathy Retrovirus,” Nature, 313:450-458 (1985). |
Wong-Staal et al., “Genomic Diversity of Human T-lymphotropic Virus Type III (HTLV-III),” Science, 229:759-762 (1985). |
Ellrodt et al., “Isolation of Human T-lymphotropic Retrovirus (LAV) from Zairian Married Couple, One with AIDS, One With Prodromes,” The Lancet, 1:1383-1385 (Jun. 23, 1984). |
Barre-Sinoussi et al., “Isolation of a T-lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS),” Science, 220:868-871 (1983). |
Yu et al., Biochem. Biophys, Res. Commun., 191:207-213. |
Peden et al., Virology, 185:661-672 (1991). |
Pennington et al., Methods Molec. Biol, 35:1-16, (1994). |
J. Virol Methods 12(1-2):85-92 (1985). |